Press Room

AAPS 2017

Start
Sunday, November 12, 2017 - 00:00
End
Wednesday, November 15, 2017 - 00:00
Location: San Diego, United States
Booth Number: 2806
Spray Drying Contract Manufacturing large capacity | Hovione

Hovione will be attending AAPS 2017 in San Diego, United States.

Schedule meeting - AAPS 2017| Hovione

HOVIONE POSTERS

Benchmarking melt processing techniques for taste masking applications

Slavomira Doktorovova, Inês Matos, Peter Stayer, Márcio Temtem, João Henriques

Bio-relevant vs traditional dissolution methodologies: a comparison study between USP II and USP IV apparatuses

Mafalda Paiva, Luís Sousa, Pedro Serôdio, Constança Cacela

Optimizing Disintegration in Tablets of Amorphous Solid Dispersions

Nuno Neves, João Henriques, Márcio Temtem

Enhancing Amorphous Solid Dispersion Miscibility and Drug Saturation through Ternary Systems

Traciann Scirbona, Michael Puppolo, Iris Duarte, João Henriques, Rui Ferreira, David Storey, Dirce Macário

Compression mechanism of HPMC-AS based amorphous solid dispersions

Slavomira Doktorovova, Clara Sá Couto, Márcio Temtem, João Henriques, Pedro Valente

Improving Efficiency of Taste Making through Spray Congealing

Inês Matos, Peter Stayer, João Henriques, Márcio Temtem

In vitro - in vivo correlations of carbamazepine nano-dispersions for application in formulation development

Michael Puppolo, Zachary WarnkenIris Duarte, Traciann Dillon, David Storey

Paddle Over Disk as a Dissolution Test for Orally Inhaled Fluticasone Propionate

Beatriz Noriega, Mafalda Paiva, Luisa Corvo, Eunice Costa, Filipa Maia

Spray Dried Composite Particles: Formulation and Process Parameters, Effect of two API Concentrations and Stability Assessment

Maria Palha, Raquel Barros, Cláudia Moura, Sofia Silva, Sara Cardoso, Eunice Costa, Márcio Temtem

Use of Supercritical-CO2 Assisted Spray Drying for the production of Pharmaceutical compounds

Cláudia Moura, Márcio Temtem, Eunice Costa

 

 

If you would like to discuss with us your projects and to find how Hovione can help, schedule a meeting with us. Adam Neunuebel will be pleased to meet you.

adam-neunuebel-photo

Adam Neunuebel

Head of Business Development

 

 

You might be also interested in

Also in the Press Room

See All

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026